US shuts door on tax inversions

Lex’s Alan Livsey and Giles Wilkes discuss the decision by the US Treasury to remove the benefit of shifting a company’s tax residence abroad, and how this will affect the recent deal between pharmaceutical companies Allergan and Pfizer.